Contacts: Anthony G. Viscogliosi, Viscogliosi Bros, LLC (212) 583-9700 ext. 100
Nick Kilsby, Creative Partners (203) 705-9202


New York, NY: February 21, 2005 - Viscogliosi Bros., LLC ("VB") recently finalized an asset purchase agreement with Xtremi-T, LLC ("Xtremi-T"), a Lawrenceville, NJ-based orthopaedics company. Xtremi-T is a technology-driven company involved in developing and marketing resorbable trauma solutions for small bone and joint surgeons and podiatrists. Under the terms of the agreement, VB received all of Xtremi-T’s assets in exchange for a one-time payment.

Founded in June 2004, Xtremi-T is focused on the development and commercialization of fixation devices and instrumentation for small bone and joint surgeons. Xtremi-T’s first product offering, Refix™, is a line of bioresorbable plates, screws, and pins with many small bone and joint applications. Xtremi-T is at an advanced stage in the regulatory process for the Refix™ product line and is expected to have full FDA approval and broad commercial distribution during 2005.

The products under development at Xtremi-T are all built from polymers that are slowly metabolized by the body. Resorbable products have a distinct advantage over many other types of fixation devices because no subsequent procedure is required to remove them. Xtremi-T’s line of products is expected to compete head-to-head with those from leading orthopedic device manufacturers.

Mr. Anthony G. Viscogliosi, a Principal at VB, said: "Xtremi-T perfectly fills a niche in VB’s current strategic direction. Shawn Huxel is a driven entrepreneur and we are certain that he will execute Xtremi-T’s plan to develop and commercialize resorbable fixation implants and instruments. Xtremi-T’s bioresorbable trauma products show significant promise and we are confident that, with our financial backing, the company’s products will quickly become the solution of choice in procedures requiring bioresorbable fixation devices."

Shawn S. Huxel, the founder and President of Xtremi-T, said: "We at Xtremi-T are excited to become part of the VB family of companies. With VB’s significant financial resources and expertise in navigating clinical and regulatory processes, we are convinced that we can bring our product to market more quickly and efficiently. I am confident that when Refix™ is commercialized, we will benefit enormously from VB’s extensive surgeon relationships."

About Viscogliosi Bros., LLC
Established by Marc R. Viscogliosi, John J. Viscogliosi and Anthony G. Viscogliosi in New York City in 1999, VB was the first venture capital/private equity and merchant banking firm dedicated to the musculoskeletal/orthopedics sector of the health care industry. Today, VB is a leading independent firm with a mission to create, build and finance companies founded on innovations developed by surgeons and uniquely focused on "life changing" musculoskeletal/orthopedic technologies. VB has worldwide surgeon, industry and trade relationships and significant financial expertise in the musculoskeletal/orthopedic sector.

As principals of VB, the Viscogliosi brothers have a combined total of more than 35 years experience analyzing and investing in the musculoskeletal/orthopedics sector. The have pioneered innovative financial, strategic and management initiatives for companies in the sector, from start-up, seed and development stage all the way to exit, while helping thousands of people lead better lives through the orthopedic and spinal products marketed and sold by the companies they have assisted in developing and financing.
> Back to Press Releases


Viscogliosi Bros., LLC is not an investment adviser, money manager, asset manager or otherwise give investment advice.